Patents by Inventor Elad BERGMAN

Elad BERGMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OCT Guided Therapy
    Publication number: 20230277126
    Abstract: Systems and relative method of monitoring the state of a subject’s retinal disease employ remote based OCT imaging of a subject’s retina. A method includes receiving optical coherence tomography (OCT) image data of a retina of a subject for each of a series of OCT imaging sessions of the retina. The OCT image data of the retina is processed to determine a series of measured extent values. Each of the one or more measured extent values is indicative of a respective extent of the retinal disease.
    Type: Application
    Filed: April 10, 2023
    Publication date: September 7, 2023
    Applicant: Notal Vision Ltd.
    Inventors: Amit Pascal, Kester Nahen, Hanoch Gideon Benyamini, Omer Rafaeli, Yair Alster, Moshe Havilio, Yael Alon, Elad Bergman
  • Early detection of reduced bone formation with an NMR scanner
    Patent number: 10478117
    Abstract: A method for early detection of bone deficiency in a patient, comprising: collecting NMR signals of a bone marrow volume in a bone of the patient having normal bone density levels which are not indicative of bone deficiency as indicated by X-ray; and analyzing said collected NMR signals to detect at least a presence or absence of a preclinical stage of bone deficiency in said bone.
    Type: Grant
    Filed: April 7, 2016
    Date of Patent: November 19, 2019
    Assignee: Ramot at Tel-Aviv University Ltd.
    Inventors: Uri Nevo, Itzhak Binderman, Yifat Sarda, Elad Bergman
  • EARLY DETECTION OF REDUCED BONE FORMATION WITH AN NMR SCANNER
    Publication number: 20180110459
    Abstract: A method for early detection of bone deficiency in a patient, comprising: collecting NMR signals of a bone marrow volume in a bone of the patient having normal bone density levels which are not indicative of bone deficiency as indicated by X-ray; and analyzing said collected NMR signals to detect at least a presence or absence of a preclinical stage of bone deficiency in said bone.
    Type: Application
    Filed: April 7, 2016
    Publication date: April 26, 2018
    Inventors: Uri NEVO, Itzhak BINDERMAN, Yifat SARDA, Elad BERGMAN